Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07170020 · ClinicalTrials.gov registry record · NA
Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections
A NA study, sponsored by Corewell Health West.
- Not yet
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT07170020 is a NA study that has not yet begun recruiting, run by Corewell Health West. The registered enrollment target is 160 participants.
The verdict
NCT07170020, a NA study, has not yet begun recruiting, sponsored by Corewell Health West.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if hyperbaric oxygen is beneficial in treating necrotizing infections and decreasing rates of morbidity and mortality. This study therefore has two aims: 1. Determine if hyperbaric oxygen improve morbidity and mortality compared to standard of care using a prospective model. 2. Determine if faster diagnosis to debridement times negate the need for hyperbaric oxygen treatments in necrotizing infections.
Interventions
- PROCEDURE Hyperbaric Oxygen Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-11-14 |
| Est. Completion | 2027-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07170020
The ClinicalTrials.gov registry entry for NCT07170020 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT07170020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07170020 about?
NCT07170020 is a clinical study titled "Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections". The goal of this clinical trial is to learn if hyperbaric oxygen is beneficial in treating necrotizing infections and decreasing rates of morbidity and mortality. This study therefore has two aims: 1. Determine if hyperbaric oxygen improve morbidity and mortality compared to standard of care using ...
What is the current status of trial NCT07170020?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-11-14. Estimated completion is 2027-11-14.
What interventions are being tested in trial NCT07170020?
The interventions under investigation include: Hyperbaric Oxygen Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT07170020?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.